Unnatural Products, Inc. (UNP) is a California-based biotech company whose platform addresses the complexities of medicinal chemistry in the macrocycle space through a combination of parallel experimentation and machine learning. Founded by macrocycle pioneers whose academic work uncovered how Nature’s macrocycles work, UNP is a team of passionate scientists and engineers. UNP is privately held and funded by ARTIS Ventures, Abstract Ventures, Asset Management Ventures, Better Ventures, Blue Bear Ventures, Merck's MSD GHI fund, Rising Tide Fund, First Spark Ventures, The Venture Collective, Humain Ventures, LongeVC, Gaingels, and Not Boring Capital.